BLOOD RHEOLOGY AND CARDIOVASCULAR RISK-FACTORS IN TYPE-1 DIABETES - RELATIONSHIP WITH MICROALBUMINURIA

被引:35
作者
JAY, RH
JONES, SL
HILL, CE
RICHMOND, W
VIBERTI, GC
RAMPLING, MW
BETTERIDGE, DJ
机构
[1] Department of Medicine, University College and Middlesex School of Medicine, The Rayne Institute
[2] Unit for Metabolic Medicine, United Medical and Dental Schools, Guy's Hospital
[3] Department of Physiology and Biophysics, St. Mary's Hospital Medical School, London
关键词
TYPE-1; DIABETES-MELLITUS; MICROALBUMINURIA; BLOOD RHEOLOGY; FIBRINOGEN; LIPIDS; LIPOPROTEINS; LIPOPROTEIN(A);
D O I
10.1111/j.1464-5491.1991.tb01674.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Whole blood and plasma viscosity, erythrocyte aggregation and deformability, plasma fibrinogen, lipids, lipoproteins, apolipoproteins, and measures of blood glucose control were compared between 21 Type 1 diabetic patients with microalbuminuria (overnight albumin excretion rate 30-200-mu-g min-1) and 21 patients with albumin excretion below this range matched for age, sex, and duration of diabetes. Patients with microalbuminuria had significantly higher glycosylated haemoglobin (9.4 +/- 1.6 (+/- SD) vs 7.9 +/- 1.8 % (normal range 5.0 to 7.6 %)), total-cholesterol (5.6 +/- 1.1 vs 4.6 +/- 1.3 mmol l-1), apolipoprotein B (0.82 +/- 0.21 vs 0.66 +/- 0.14 g l-1), and apolipoprotein B:A1 ratio (0.58 +/- 0.18 vs 0.50 +/- 0.15) than those without microalbuminuria (all p < 0.05). HDL-cholesterol was also raised (1.71 +/- 0.46 vs 1.43 +/- 0.37 mmol l-1, p < 0.05). Lipoprotein(a) concentration was possibly higher in the microalbuminuric group (median (95 % Cl) 105 (82-140) vs 72 (52-114) mg l-1, p = 0.06). No differences were seen in any of the rheological measurements. These results confirm the presence of potentially atherogenic lipoprotein changes in Type 1 diabetic patients with microalbuminuria, but suggest that altered blood rheology does not predate the development of nephropathy.
引用
收藏
页码:662 / 667
页数:6
相关论文
共 43 条
[1]  
Borch-Johnsen K., Andersen PK, Deckert T., The effect of proteinuria on relative mortality in type 1 (insulin‐dependent) diabetes mellitus, Diabetologia, 28, pp. 590-596, (1985)
[2]  
Borch-Johnsen K., Kreiner S., Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus, BMJ, 294, pp. 1651-1654, (1987)
[3]  
Krolewski AS, Kosinski EJ, Warram JH, Et al., Magnitude and determinants of coronary artery disease in juvenile‐onset, insulin‐dependent diabetes mellitus, Am J Cardiol, 59, pp. 750-755, (1987)
[4]  
Winocour PH, Durrington PN, Ishola M., Anderson DC, Cohen H., Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin‐dependent diabetes mellitus, Br Med J, 294, pp. 1648-1651, (1987)
[5]  
Jensen T., Borch-Johnsen K., Kofoed-Enevoldsen A., Deckert T., Coronary heart disease in young type 1 (insulin‐dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors, Diabetologia, 30, pp. 144-148, (1987)
[6]  
Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A., Mahmud U., Keen H., Microalbuminuria as a predictor of clinical nephropathy in insulin‐dependent diabetes mellitus, Lancet, 1, pp. 1430-1432, (1982)
[7]  
Mathieson ER, Oxenboll B., Johansen K., Svendsen PA, Deckert T., Incipient nephropathy in type 1 (insulin‐dependent) diabetes, Diabetologia, 26, pp. 406-410, (1984)
[8]  
Mogensen CE, Christensen CK, Predicting diabetic nephropathy in insulin‐dependent patients, N Engl J Med, 311, pp. 89-93, (1984)
[9]  
Mogensen CE, Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes, N Engl J Med, 6, pp. 356-360, (1984)
[10]  
Schmitz A., Vaeth M., Microalbuminuria: a major risk factor in non‐insulin‐dependent diabetes. A 10 year follow‐up study of 503 patients, Diabetic Med, 5, pp. 126-134, (1988)